Kumaraguru Raja
Stock Analyst at Brookline Capital Markets
(0.25)
# 4,576
Out of 5,055 analysts
199
Total ratings
31.4%
Success rate
-5.5%
Average return
Main Sectors:
Stocks Rated by Kumaraguru Raja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion | Initiated Coverage: Buy | $10 | $0.834 | +1,099.04% | 1 | Oct 7, 2026 | |
| EDSA Edesa Biotech | Initiated Coverage: Buy | $18 → $21 | $2.65 | +692.45% | 10 | Jun 29, 2026 | |
| ERNA Ernexa Therapeutics | Initiated Coverage: Buy | $30 | $2.11 | +1,321.80% | 1 | May 7, 2026 | |
| IRD Opus Genetics | Initiated Coverage: Buy | $10 → $8 | $4.10 | +95.12% | 4 | Dec 1, 2025 | |
| MDCX Medicus Pharma | Reiterated: Buy | $12 → $20 | $3.12 | n/a | 2 | Sep 24, 2025 | |
| NBP NovaBridge Biosciences | Reiterated: Buy | $6 → $8 | $1.28 | n/a | 2 | Aug 28, 2025 | |
| INTS Intensity Therapeutics | Upgraded: Buy | $75 | $3.42 | n/a | 2 | Aug 12, 2025 | |
| ADIL Adial Pharmaceuticals | Reiterated: Buy | $8 → $50 | $3.00 | n/a | 4 | Jun 26, 2025 | |
| HURA TuHURA Biosciences | Initiated Coverage: Buy | $9 | $1.76 | n/a | 1 | Jun 23, 2025 | |
| MNPR Monopar Therapeutics | Reiterated: Buy | $3 → $58 | $73.10 | n/a | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $1.48 | n/a | 1 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $1.39 | n/a | 1 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $3.70 | n/a | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $2.49 | n/a | 1 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.6602 | n/a | 1 | Jun 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1.2 | $0.6356 | n/a | 3 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $0.1833 | n/a | 1 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 → $5 | $0.729 | n/a | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $74 | $0.000001 | n/a | 5 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $330 | $0.0003 | n/a | 3 | Oct 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.94 | n/a | 9 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.4702 | n/a | 9 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $2.13 | n/a | 20 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 | $11.12 | n/a | 15 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $7 | $0.4575 | n/a | 8 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.9272 | n/a | 6 | Aug 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $2.61 | n/a | 6 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.02 | n/a | 5 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $0.8945 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14.00 | $0.44 | n/a | 5 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $1.04 | n/a | 8 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $2 | $0.6633 | n/a | 2 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.78 | n/a | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $0.09115 | n/a | 5 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $4.94 | n/a | 1 | Feb 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $0.0001 | n/a | 9 | Dec 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.18 | n/a | 3 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.48 | n/a | 2 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8412 | n/a | 3 | Dec 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $4.41 | n/a | 4 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.40 | n/a | 1 | Aug 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.97 | n/a | 2 | Aug 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.05 | n/a | 1 | May 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.49 | n/a | 2 | May 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $2.18 | n/a | 1 | May 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.362 | n/a | 1 | May 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.5 → $0.4 | $11.88 | n/a | 2 | Jun 29, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $537 → $480 | $778.36 | n/a | 4 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $153.54 | n/a | 1 | Apr 6, 2015 |
Biomea Fusion
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $0.834
Upside: +1,099.04%
Edesa Biotech
Jun 29, 2026
Initiated Coverage: Buy
Price Target: $18 → $21
Current: $2.65
Upside: +692.45%
Ernexa Therapeutics
May 7, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $2.11
Upside: +1,321.80%
Opus Genetics
Dec 1, 2025
Initiated Coverage: Buy
Price Target: $10 → $8
Current: $4.10
Upside: +95.12%
Medicus Pharma
Sep 24, 2025
Reiterated: Buy
Price Target: $12 → $20
Current: $3.12
Upside: n/a
NovaBridge Biosciences
Aug 28, 2025
Reiterated: Buy
Price Target: $6 → $8
Current: $1.28
Upside: n/a
Intensity Therapeutics
Aug 12, 2025
Upgraded: Buy
Price Target: $75
Current: $3.42
Upside: n/a
Adial Pharmaceuticals
Jun 26, 2025
Reiterated: Buy
Price Target: $8 → $50
Current: $3.00
Upside: n/a
TuHURA Biosciences
Jun 23, 2025
Initiated Coverage: Buy
Price Target: $9
Current: $1.76
Upside: n/a
Monopar Therapeutics
May 13, 2025
Reiterated: Buy
Price Target: $3 → $58
Current: $73.10
Upside: n/a
Nov 20, 2024
Initiated Coverage: Buy
Price Target: $38
Current: $1.48
Upside: n/a
Aug 22, 2024
Initiated Coverage: Buy
Price Target: $9
Current: $1.39
Upside: n/a
Jul 9, 2024
Initiated Coverage: Buy
Price Target: $80
Current: $3.70
Upside: n/a
Jun 6, 2024
Initiated Coverage: Buy
Price Target: $8
Current: $2.49
Upside: n/a
Jun 29, 2023
Initiated Coverage: Buy
Price Target: $15
Current: $0.6602
Upside: n/a
May 30, 2023
Downgraded: Hold
Price Target: $2 → $1.2
Current: $0.6356
Upside: n/a
Mar 3, 2023
Initiated Coverage: Buy
Price Target: $9
Current: $0.1833
Upside: n/a
Jan 5, 2023
Initiated Coverage: Buy
Price Target: $6 → $5
Current: $0.729
Upside: n/a
Nov 29, 2022
Reiterated: Buy
Price Target: $80 → $74
Current: $0.000001
Upside: n/a
Oct 17, 2022
Reiterated: Buy
Price Target: $12 → $330
Current: $0.0003
Upside: n/a
Aug 15, 2022
Reiterated: Buy
Price Target: n/a
Current: $3.94
Upside: n/a
Aug 11, 2022
Reiterated: Buy
Price Target: $6
Current: $0.4702
Upside: n/a
Aug 11, 2022
Reiterated: Buy
Price Target: $31
Current: $2.13
Upside: n/a
Aug 10, 2022
Reiterated: Buy
Price Target: $74
Current: $11.12
Upside: n/a
Aug 8, 2022
Rated: Buy
Price Target: $10 → $7
Current: $0.4575
Upside: n/a
Aug 1, 2022
Reiterated: Buy
Price Target: n/a
Current: $0.9272
Upside: n/a
Jun 2, 2022
Reiterated: Buy
Price Target: $12
Current: $2.61
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: n/a
Current: $1.02
Upside: n/a
May 13, 2022
Reiterated: Buy
Price Target: $22
Current: $0.8945
Upside: n/a
May 2, 2022
Reiterated: Buy
Price Target: $14.00
Current: $0.44
Upside: n/a
Apr 5, 2022
Reiterated: Buy
Price Target: $45
Current: $1.04
Upside: n/a
Sep 28, 2021
Reiterated: Buy
Price Target: $14 → $2
Current: $0.6633
Upside: n/a
Aug 17, 2021
Reiterated: Buy
Price Target: $7
Current: $2.78
Upside: n/a
Mar 23, 2021
Reiterated: Buy
Price Target: $12 → $6
Current: $0.09115
Upside: n/a
Feb 2, 2021
Initiated Coverage: Buy
Price Target: $10
Current: $4.94
Upside: n/a
Dec 16, 2020
Reiterated: Buy
Price Target: $35
Current: $0.0001
Upside: n/a
Feb 20, 2020
Reiterated: Buy
Price Target: $6
Current: $1.18
Upside: n/a
Mar 28, 2019
Rated: Hold
Price Target: n/a
Current: $2.48
Upside: n/a
Dec 24, 2018
Rated: Hold
Price Target: n/a
Current: $0.8412
Upside: n/a
Oct 22, 2018
Reiterated: Buy
Price Target: $25
Current: $4.41
Upside: n/a
Aug 30, 2018
Reiterated: Hold
Price Target: n/a
Current: $6.40
Upside: n/a
Aug 4, 2017
Reiterated: Buy
Price Target: n/a
Current: $1.97
Upside: n/a
May 26, 2017
Reiterated: Buy
Price Target: n/a
Current: $8.05
Upside: n/a
May 22, 2017
Reiterated: Buy
Price Target: n/a
Current: $1.49
Upside: n/a
May 16, 2017
Reiterated: Hold
Price Target: $10
Current: $2.18
Upside: n/a
May 10, 2017
Reiterated: Buy
Price Target: n/a
Current: $0.362
Upside: n/a
Jun 29, 2016
Downgraded: Hold
Price Target: $3.5 → $0.4
Current: $11.88
Upside: n/a
Feb 25, 2016
Initiated Coverage: Buy
Price Target: $537 → $480
Current: $778.36
Upside: n/a
Apr 6, 2015
Reiterated: Buy
Price Target: $120
Current: $153.54
Upside: n/a